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ABSTRACT
G-protein coupled receptors (GPCRs) represent one
of the most important families of drug targets in
pharmaceutical development. GLIDA is a public
GPCR-related Chemical Genomics database that is
primarily focused on the integration of information
between GPCRs and their ligands. It provides
interaction data between GPCRs and their ligands,
along with chemical information on the ligands, as
well as biological information regarding GPCRs.
These data are connected with each other in a
relational database, allowing users in the field of
Chemical Genomics research to easily retrieve
such information from either biological or chemical
starting points. GLIDA includes a variety of simi-
larity search functions for the GPCRs and for
their ligands. Thus, GLIDA can provide correlation
maps linking the searched homologous GPCRs
(or ligands) with their ligands (or GPCRs). By
analyzing the correlation patterns between GPCRs
and ligands, we can gain more detailed knowledge
about their conserved molecular recognition pat-
terns and improve drug design efforts by focusing
on inferred candidates for GPCR-specific drugs.
This article provides a summary of the GLIDA
database and user facilities, and describes recent
improvements to database design, data contents,
ligand classification programs, similarity search
options and graphical interfaces. GLIDA is publicly
available at http://pharminfo.pharm.kyoto-u.ac.jp/
services/glida/. We hope that it will prove very
useful for Chemical Genomics research and GPCR-
related drug discovery.
INTRODUCTION
The family of G-protein coupled receptors (GPCRs)
represents one of the most important classes of pharma-
ceutical targets (1). Among the more than 1000 GPCRs
encoded in the human genome, more than 400 are of
potential therapeutic interest (2). Currently the drugs
available on the market address only 30 GPCRs, which
represent a small fraction of the GPCR target family.
A large majority of human-derived GPCRs still remain
promising drug targets, and thus a key goal of GPCR
research related to drug design is to identify new ligands
for such target GPCRs.
With the unprecedented accumulation of genomic
information, databases and bioinformatics have become
essential tools to guide GPCR research (3). The GPCRDB
(2) and IUPHAR receptor database (IUPHAR-RD)
(4) are representatives of widely used public databases
covering GPCRs. These databases, which provide sub-
stantial data on the GPCR proteins and pharmacological
information on receptor proteins containing GPCRs, are
mainly focused on biological aspects of the GPCR gene
products or proteins. In spite of the signiﬁcance of ligand
compounds as drug leads, the relationships between
GPCRs and their ligands and/or chemical information
on the ligands themselves are not yet fully covered.
On the other hand, there is increasing interest in
publicly collecting and applying chemical as well as
biological information in the post-genome era (5–8).
This new trend is called ‘Chemical Genomics’, and it
aims to identify all possible chemical ligands and drugs for
all targets families (9,10). There is a vast amount of
information on the interactions between small molecules
and proteins/genes. However, compound–protein interac-
tions have not yet been analyzed on a large scale, and
there are no eﬀective methods to extract meaningful
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Therefore, we need to integrate chemoinformatics and
bioinformatics into a common computational platform
for mining of Chemical Genomics data (11).
GLIDA (GPCR-Ligand DAtabase) is a public GPCR-
related Chemical Genomics database designed to simulta-
neously mine biological information on GPCRs and
chemical information on their ligands. It provides various
analytical data regarding GPCR–ligand correlations by
incorporating bioinformatics and chemoinformatics tech-
niques, and thus it should prove very useful for GPCR-
related drug discovery from the viewpoint of Chemical
Genomics research. There have been several major
improvements to GLIDA since it was last described in
Ref. (12): (i) there are more increments in the entries of the
ligands and the corresponding ligand–GPCR pairs; (ii) the
ligands are originally classiﬁed using a new strategy;
(iii) additional options are available within the similarity
search program for the GPCRs and ligands and (iv) the
graphical interface to display the correlation maps
between GPCRs and ligands has been enhanced.
DATA CONTENTS
GLIDA contains three types of primary data: biological
information on GPCRs, chemical information on their
ligands and information on binding of the GPCR–ligand
pairs. The GPCR entries were acquired from human,
mouse and rat entries deposited in the GPCRDB because
these three species include suﬃcient information regarding
ligands, and rats and mice are representative model
animals used in drug discovery research. The ligand-
binding information was manually collected and curated
using various public web sites and commercial databases
such as the IUPHAR-RD, PubMed (5), PubChem (5),
DrugBank (13), Ki Database (14) and MDL ISIS/Base
2.5. Table 1 indicates the size and scope of the GLIDA
database. In particular, we have dramatically expanded
the entry number of ligands and the corresponding
ligand–GPCR pairs. The latest GLIDA version includes
24077 ligand entries and 39140 GPCR–ligand pair
entries, representing nearly 35-fold and 20-fold increases,
respectively, since the last publication of GLIDA in 2006.
The total number of GPCR entries remains unchanged,
but entries with associated ligand information have
increased slightly, suggesting that it is diﬃcult to
de-orphan the GPCRs whose ligands have not yet been
identiﬁed (15).
GPCR and ligand data
The database lists general information on GPCR and
ligand data, respectively. The general information table
listing GPCRs contains gene names, family names, protein
sequences (in fasta format) and links to other biological
databases, such as GPCRDB, UniProt (16), IUPHAR-
RD, Entrez Gene (17) and KEGG (18). The ligand result
page provides a general information table containing
names, molecular structures, CAS registry numbers,
formulas, molecular weights, structure ﬁles and links to
PubChem, KEGG, ChEBI (8) and DrugBank that are in
publicly available chemical databases.
Information on binding ofGPCR–ligand pairs
The interaction information relating GPCRs to particular
ligands, a key issue for GPCR-related drug discovery, is
deposited in a relational database. GLIDA allows users to
retrieve GPCR–ligand-binding information dynamically
and continuously. When users retrieve a GPCR (or ligand)
entry, its result page displays all entries showing the cor-
responding ligands (or GPCR) entries with their binding
activity types, as well as references. The references are
hyperlinked with the corresponding PubMed literature.
The activity types include agonist, antagonist and full,
partial or inverse agonist (Table 1). Here the detail
annotations such as full, partial or inverse agonist are
not ﬁnished yet. The ligands classiﬁed as agonists are
possible full agonists or partial agonists. Inverse agonists
can be also contained among the antagonists.
WEB INTERFACE AND APPLICATION
GLIDA is available at http://pharminfo.pharm.kyoto-u.
ac.jp/services/glida/. The web interface of GLIDA includes
a GPCR search page (Figure 1a) and a ligand search page
(Figure 1b). Each page consists of a classiﬁcation menu
and a keyword search box. The users can search a
GPCR (or ligand) manually using the classiﬁcation tool,
Table 1. The current numbers of GLIDA ligands and GPCRs and their
respective links.
Information item Number of entries
GPCR entries 3738
Links to Entrez Gene 3073
Links to GPCRDB 3738
Links to UniProt 3738
Links to IUPHAR 446
Links to KEGG 595
Ligand entries 24077
Cas registry number 2425
Molecular structure 23216
a
Links to PubChem 1821
Links to ChEBI 103
Links to KEGG 664
Links to DrugBank 479
Cluster number 300
b
GPCR–ligand pair entries 39140
GPCR entries 410
Ligand entries 24077
Activity
Agonist 8305
Full Agonist 2325
Partial Agonist 262
Antagonist 28132
Inverse Agonist 116
aMolecular structures consist of MDL MOL ﬁles and original ﬁles
converted into KEGG atom types. The numbers of MDL MOL ﬁles
and KEGG-type ﬁles are 23216 and 23214, respectively. PCA
calculation was performed for 23214 KEGG-type ﬁles.
bThis cluster number (300) is diﬀerent from the number of the
selected principal components (314). No compounds were assigned to
14 principal components.
D908 Nucleic Acids Research, 2008, Vol. 36, DatabaseissueFigure 1. A screenshot of GLIDA showing linked relations among search pages (a and b), result pages (c and d), an analytical report page (e), and a
binding information page (f). The analytical report page consists of a correlation map and a list resulting from a similarity search. Red and blue
colors of the spots on the correlation map indicate the ligand activities of antagonists including inverse agonist and agonists including full/partial
agonist, respectively.
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Every GPCR (or ligand) has its own results page (Figure 1c
or d) containing a general information table regarding
a GPCR (or ligand), a table of its correlated ligands
(or GPCRs) and a menu button to carry out a similarity
search and correlation analysis.
Classification of GPCRs and ligands
The GPCR classiﬁcation table on the search page was
adapted from the phylogenetic tree within the GPCRDB
information system (http://www.gpcr.org/7tm/phylo/
phylo.html). The GPCR classiﬁcation table displays the
entries of the corresponding GPCRs at the tree branches,
and these are hyperlinked with the corresponding result
pages (Figure 1a). GLIDA also provides an original
ligand classiﬁcation (Figures 1b and 2). With the great
increase in ligand entries, we have to improve our method
of classifying all the ligands in GLIDA. Hierarchical
clustering and its tree representation, which were used in
the old version of GLIDA, are unsuitable for the data
mining of huge chemical databases. We therefore have
adopted principal component analysis (PCA) for cluster-
ing of 23214 ligand structures in this new version, as
follows. We generated frequency proﬁles of the atoms and
the bonds converted into the KEGG atom types from
MDL MOL ﬁles of ligand entries (19). The KEGG-type
proﬁle for each ligand is shown in ‘Struct. ﬁle’ item of
Figure 2. A screenshot of the ligand search process on the ligand classiﬁcation page. Users can search the ligands from two starting points: keyword
search and cluster selection. If they have a chemical structure of their query compound, the ligand search is performed using the cluster selection tool
as follows. Selecting a set of atom types (step 1) that the query compound contains, the pull-down menu of cluster selection displays the list of the
only clusters that include selected atom types as the principal components (step 2). By selecting a cluster from the list, users can check the principal
component’s atoms on the upper right section of the page. Finally, upon clicking the search button, GLIDA displays the list of all ligands classiﬁed
in the selected cluster (step 3). The ‘Atom Type TABLE’ button links the user to the page showing the cluster size and representative atom types for
each cluster.
D910 Nucleic Acids Research, 2008, Vol. 36, Databaseissuegeneral information table of GLIDA. PCA was applied to
the data matrix consisting of 700 KEGG-type features’
columns and 23214 ligand entries’ rows. The resulting
principal components (PCs) constitute a new set of
linearly independent, orthogonal axes that capture the
directions of maximum variance in the data. The samples
(chemical compounds) were then projected onto these PC
axes. Herein, we used the top 314 PCs as seeds of clusters
that account for >80% (cumulative proportion) of the
total variance. Finally, each compound was assigned to
the PC cluster having the maximum score among the 314
PCs. In order to annotate the features of each cluster (PC),
we selected for each PC the atom types and their bonds
corresponding to the top 10 loadings having the largest
magnitude. The ligand classiﬁcation page displays
a table of all the atom types selected by PCA (Figure 2).
By clicking on some of the atoms in this table, users can
search clusters that include the selected atom types.
Consequently, the ligands relevant to users’ interests are
included in the retrieved cluster.
Similarity search and correlation mapforGPCRs
and ligands
The fact that similar proteins bind similar ligands is the
underlying principle of the Chemical Genomics approach
to drug discovery (11). GLIDA has a variety of similarity
search functions for GPCRs and ligands, respectively, on
its result pages (Figure 1c or d). Alignment scores for
protein sequences generated by the BLAST algorithm
provide similarity measures for GPCRs. In addition to
sequence similarity, gene expression patterns in tissue
origins and developmental stages were used as similarity
measures. The expression data for each GPCR was
generated from the EST sequences in diﬀerent libraries
served from NCBI/Unigene (http://www.ncbi.nlm.nih.
gov/UniGene/ddd.cgi). We can thereby retrieve the
GPCRs that present tissue-/stage-speciﬁc distribution
similar to a query GPCR. For example, co-expression
information on speciﬁc GPCRs enables us to speculate
about GPCR-heterodimerization that might have an eﬀect
on their activity (1). Ligand similarity is deﬁned by the
dissimilarity (distance) of frequency proﬁle patterns
generated from the constitutive atoms and bonds of the
chemical structure, using the KEGG atom types (19,20).
From the similarity search, the most similar GPCRs (or
ligands) within the users’ selected parameters are retrieved
and listed with their similarity scores on an analytical
report page (Figure 1e). In the latest GLIDA version,
various parameters have been added as search options,
such as selections of species, ligand activities, displayed
number of GPCRs/ligands and map graphical mode.
As another result of similarity search calculations,
GLIDA illustrates the correlation map (Figure 1e) show-
ing homologous GPCRs (or ligands) and their ligands
(or GPCRs) that are retrieved. This map shows spots that
match the GPCRs and their ligands in a 2D matrix. The
ordering along the x-axis and the y-axis are calculated
respectively by two-way clustering of the GPCRs and
the ligands, based on their similarities. In particular, the
ordering along the x- and y-axes allows users to evaluate
the sequence similarities among GPCRs and the correla-
tion coeﬃcients among ligands simultaneously. By analyz-
ing the correlation patterns between GPCRs and ligands
that are illustrated by these maps, we can gain detailed
knowledge about their interactions. We can then utilize
this information to infer possible candidates for develop-
ment of GPCR-speciﬁc drugs. Furthermore, we have
enhanced a graphical interface to display the correlation
map between GPCRs and ligands. Graphics are an
important tool to aid visualization and interpretation of
high-dimensional data. The old version of GLIDA used
only the PNG (Portable Network Graphics) format to
display a GPCR–ligand correlation map. Due to the great
increase in entries, the latest GLIDA version introduces
the SVG (Scalable Vector Graphics) format, which is
adaptable to an enormous correlation map size. The SVG
vector image can be scaled indeﬁnitely without loss of
image quality, while the PNG bitmap image cannot. Users
must install the free plug-in software on their computer in
advance to use the SVG format (http://www.adobe.com/
svg/viewer/install/). In the case of uninstalled devices,
PNG representation should be selected as a graphical
mode. Figure 1 shows an example of the GPCR–ligand
search and analysis process starting from a GPCR query
using GLIDA.
DISCUSSION AND FUTURE DIRECTIONS
GLIDA provides a unique database useful for GPCR-
related Chemical Genomics research and drug discovery.
GLIDA is distinct from other public Chemical Genomics
databases because it contains original, GPCR-speciﬁc
chemical entries and oﬀers a common mining platform of
bioinformatics and chemoinformatics. GLIDA provides
several advantages over other databases, in that a search
can be started either from a GPCR or from a ligand. Thus,
searches can be carried out in a dynamic and user-friendly
way. GLIDA’s coverage of chemical and biological
information simultaneously also provides an advantage
to users by saving them the time and labor required to
search multiple databases. The ligand search page is
another distinct characteristic of GLIDA, in that it
displays the structural distribution of ligands. It thereby
facilitates research on GPCR-related drugs by incorporat-
ing structural aspects of the ligand compounds into the
search. The analytical report pages resulting from the
calculated structural similarities of GPCRs and ligands
can give the user deep insights into the GPCR–ligand
relationships. The lists of neighboring ligands (or GPCRs)
and the correlation maps are useful visualization tools for
analyzing correlations among the structural features and
the GPCR–ligand-binding properties. Because this data-
base system can be applied to proteins other than the
GPCR family, it may also be considered as a promising
database for other types of Chemical Genomics research.
One critical issue is how to deﬁne similarity metrics for
proteins and ligands, because the underlying principle of
GLIDA is that similar receptors bind similar ligands. For
example, ligand similarity can be deﬁned by manifold
representations such as graph, ﬁngerprint and descriptors.
Nucleic Acids Research, 2008,Vol. 36,Database issue D911Protein similarity can be also measured in diﬀerent ways
such as overall sequence homology (phylogenetic relation-
ships), consensus motifs, common binding sites, 3D
structures and reported functional annotations.
Therefore we will add new menus incorporating these
various similarity metrics for GPCRs and ligands.
GLIDA will be updated continuously. In particular, we
are now planning to add the drawing tool of chemical
structures and to expand the ligand-searching function for
an arbitrary chemical query.
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